Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 11/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 10/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 10/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 10/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | PNMT | P11086 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4216825 | 0.85 | OPRL1 (0.40) | LTA4HOPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL348028 | 0.79 | PNMT (0.54) | OPRL1OPRM1OPRD1OPRK1PNMT | |
| Hydrochloric Acid SCHEMBL29535702 | 0.77 | PNMT (0.52) | OPRL1OPRM1OPRD1OPRK1PNMT | |
| SCHEMBL2969459 | 0.72 | OPRL1 (0.39) | OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL8671295 | 0.72 | SMN1; SMN2 (0.58) | SMN1; SMN2CA12CA1CA2CA9 | |
| Diphenylmethanol SCHEMBL29133267 | 0.71 | CHRNB4 (0.44) | LTA4HCHRNB4CHRNA3SMN1; SMN2 | |
| Diphenylmethanol SCHEMBL41571 | 0.69 | SMN1; SMN2 (0.61) | SMN1; SMN2CA12CA1CA2CA9 | |
| Diphenylmethanol SCHEMBL6434457 | 0.69 | SMN1; SMN2 (0.61) | SMN1; SMN2CA12CA1CA2CA9 | |
| Diphenylmethanol SCHEMBL10868602 | 0.69 | SMN1; SMN2 (0.61) | SMN1; SMN2CA12CA1CA2CA9 | |
| Diphenylmethanol SCHEMBL11564700 | 0.69 | SMN1; SMN2 (0.61) | SMN1; SMN2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160002220-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LTD (GB) | 2016-01-07 | — | — | US | disclosed |
| US-9144571-B2 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2015-09-29 | — | — | US | disclosed |
| US-20150238470-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2015-08-27 | — | — | US | disclosed |
| US-9045469-B2 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2015-06-02 | — | — | US | disclosed |
| US-20140371264-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2014-12-18 | — | — | US | disclosed |
| US-8853404-B2 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2014-10-07 | — | — | US | disclosed |
| US-20140080863-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2014-03-20 | — | — | US | disclosed |
| US-8575347-B2 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2013-11-05 | — | — | US | disclosed |
| EP-2570128-A1 | Muscarinic acetylcholine receptor antagonists | Glaxo Group Limited (GB) | 2013-03-20 | — | — | EP | disclosed |
| US-20130030015-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2013-01-31 | — | — | US | disclosed |
| US-8309572-B2 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2012-11-13 | — | — | US | disclosed |
| US-20120157491-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2012-06-21 | — | — | US | disclosed |
| US-8183257-B2 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2012-05-22 | — | — | US | disclosed |
| US-20090124653-A1 | Muscarinic Acetylcholine Receptor Antagonists | GLAXO GROUP LIMITED (GB) | 2009-05-14 | — | — | US | disclosed |
| US-7498440-B2 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2009-03-03 | — | — | US | disclosed |
| US-7488827-B2 | Muscle relaxants; respiratory system disorders; asthma;COPD; emphysema; bronchitis | GLAXO GROUP LIMITED (GB) | 2009-02-10 | — | — | US | disclosed |
| US-20070249664-A1 | Muscarinic Acetylcholine Receptor Antagonists | GLAXO GROUP LIMITED | 2007-10-25 | — | — | US | disclosed |
| US-20070185155-A1 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249664-A1 | Muscarinic Acetylcholine Receptor Antagonists | CHRM3, CHRNG, CHRM2 | LTA4H 697/4885OPRL1 33/4885OPRM1 34/4885 |
| US-20090124653-A1 | Muscarinic Acetylcholine Receptor Antagonists | CHRM3, CHRNG, CHRM2 | LTA4H 697/4885OPRL1 33/4885OPRM1 34/4885 |
| US-20160002220-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | CHRM3, CHRNG, CHRM2 | LTA4H 611/4885OPRL1 39/4885OPRM1 34/4885 |
| US-20140080863-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | CHRM3, CHRNG, CHRM2 | LTA4H 697/4885OPRL1 33/4885OPRM1 34/4885 |
| US-20130030015-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | CHRM3, CHRNG, CHRM2 | LTA4H 697/4885OPRL1 33/4885OPRM1 34/4885 |
| US-20140371264-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | CHRM3, CHRNG, CHRM2 | LTA4H 697/4885OPRL1 33/4885OPRM1 34/4885 |
| US-20150238470-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | CHRM3, CHRNG, CHRM2 | LTA4H 611/4885OPRL1 39/4885OPRM1 34/4885 |
| US-20120157491-A1 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | CHRM3, CHRNG, CHRM2 | LTA4H 697/4885OPRL1 33/4885OPRM1 34/4885 |
| US-20070185155-A1 | Muscarinic acetylcholine receptor antagonists | CHRM3, CHRNG, CHRM2 | LTA4H 697/4885OPRL1 33/4885OPRM1 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.